Diagnosis and treatment of pulmonary infection secondary to empyema complicated with lung cancer: a case report.

BACKGROUND

This study aimed to explore the clinical characteristics, diagnosis, and management of Invasive Pulmonary (IPA) complicating empyema in a patient with lung cancer.

CASE PRESENTATION

We analyzed the clinical manifestations, bronchoscopic findings, and therapeutic approaches, including anti-infective and anti-tumor treatments, in a patient diagnosed with IPA-associated empyema and lung cancer. Histopathological examination of bronchoscopic biopsy specimens confirmed pulmonary adenocarcinoma, while bronchoalveolar lavage fluid cultures identified . Following the development of secondary empyema, comprehensive anti-infective and anti-tumor therapies were administered, leading to disease control. IPA-associated empyema complicating lung cancer represents a rare clinical scenario.

CONCLUSION

In patients presenting with IPA, the potential coexistence of lung cancer should be considered. An integrated approach combining antifungal therapy and active anti-tumor treatment is essential for managing such cases.